1. Home
  2. ARBB vs UBX Comparison

ARBB vs UBX Comparison

Compare ARBB & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBB
  • UBX
  • Stock Information
  • Founded
  • ARBB 1997
  • UBX 2009
  • Country
  • ARBB Singapore
  • UBX United States
  • Employees
  • ARBB N/A
  • UBX N/A
  • Industry
  • ARBB EDP Services
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARBB Technology
  • UBX Health Care
  • Exchange
  • ARBB Nasdaq
  • UBX Nasdaq
  • Market Cap
  • ARBB 11.9M
  • UBX 13.9M
  • IPO Year
  • ARBB 2023
  • UBX 2018
  • Fundamental
  • Price
  • ARBB $6.96
  • UBX $0.81
  • Analyst Decision
  • ARBB Strong Buy
  • UBX Strong Buy
  • Analyst Count
  • ARBB 1
  • UBX 3
  • Target Price
  • ARBB $20.00
  • UBX $4.67
  • AVG Volume (30 Days)
  • ARBB 17.5K
  • UBX 545.0K
  • Earning Date
  • ARBB 06-27-2025
  • UBX 08-05-2025
  • Dividend Yield
  • ARBB N/A
  • UBX N/A
  • EPS Growth
  • ARBB N/A
  • UBX N/A
  • EPS
  • ARBB N/A
  • UBX N/A
  • Revenue
  • ARBB $24,425,491.00
  • UBX N/A
  • Revenue This Year
  • ARBB N/A
  • UBX N/A
  • Revenue Next Year
  • ARBB N/A
  • UBX N/A
  • P/E Ratio
  • ARBB N/A
  • UBX N/A
  • Revenue Growth
  • ARBB N/A
  • UBX N/A
  • 52 Week Low
  • ARBB $3.22
  • UBX $0.66
  • 52 Week High
  • ARBB $18.60
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • ARBB 43.03
  • UBX 49.77
  • Support Level
  • ARBB $6.48
  • UBX $0.67
  • Resistance Level
  • ARBB $7.46
  • UBX $0.85
  • Average True Range (ATR)
  • ARBB 0.63
  • UBX 0.08
  • MACD
  • ARBB 0.14
  • UBX 0.02
  • Stochastic Oscillator
  • ARBB 75.92
  • UBX 29.04

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: